Cytokinetics Inc 10-Q for FY2026 Q3
Cytokinetics Inc (CYTK)
10-Q
2026-11-04
For: 2026-09-30
View Original
Added on
November 04, 2026
About this 10-Q
Cytokinetics Inc filed this 10-Q on November 4, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $47.56M
- up 2356.5% from $1.94M a year earlier
- Net loss
- $190.07M
- compared with a net loss of $306.18M a year earlier
- Diluted EPS
- -$1.37
- compared with -$2.55 a year earlier